Brief: Matthew Nachtrab Reports 27.7% Stake In Reshape Lifesciences As Of Feb 6 - SEC Filing

Vyome Holdings

15/02/2023 20:53

Feb 15 (Reuters) - 
  
    * MATTHEW NACHTRAB REPORTS 27.7% STAKE IN RESHAPE
LIFESCIENCES AS
OF FEB 6 - SEC FILING
    * NACHTRAB-PURCHASED CO'S COMMON STOCK BASED ON BELIEF THAT
SUCH
SECURITIES, AT CURRENT MARKET PRICES, REPRESENTED AN ATTRACTIVE
INVESTMENT OPPORTUNITY
    * NACHTRAB - WROTE A LETTER TO THE CEO OF CO WITH
RECOMMENDATIONS
FOR THE MANAGEMENT TEAM’S STRATEGY GOING FORWARD

Source text:(https://bit.ly/3IoQdQq)
Further company coverage: RSLS.O 
 ((Reuters.Briefs@thomsonreuters.com;))